ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Mass. Democrats, NCCS, To Provide Bracelets, Information In Honor Of Kennedy.

June 6, 2008

AACR To Screen Attendees From SARS-Affected Areas.

June 20, 2003

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014